Advertisement

ATXI

Avenue Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · ATXI

All alert types
0.38 USD 0.00 0.00%
As of Oct 29, 2026 Extended hours 0.40 +5.21%
Bid
0.40 × 5,000
Ask
0.42 × 13,166
0.40 Day range 0.40
0.15 52-week range 0.9233
YTD
-44.13%
1 year
-46.87%
Open
0.40
Prev close
0.38
Mkt cap
1.25M
Vol
5.00K
Avg vol
5.85K
EPS
-0.85
P/E
0.00
Div yield
0.00%
More statistics
Low
0.40
High
0.40
Forward P/E
-0.55
Beta
-0.18
Short ratio
0.73
Inst. own
10.33%
Dividend
0.00
Ex-div date
50-d avg
2.02
200-d avg
4.18
1y target
8.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ATXI has not been loaded yet. Try again in a moment.

Ownership

Held by insiders 9.85%
Held by institutions 10.33%
Float held by institutions 11.46%
Institutions 9

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Armistice Capital, LLC5.60%115,000197.80KSep 29, 2024
Sabby Management, LLC3.07%63,060108.46KSep 29, 2024
Moss Adams Wealth Advisors LLC 0.54%11,00018.92KSep 29, 2024
UBS Group AG0.30%6,14310.56KSep 29, 2024
Tower Research Capital LLC (TRC)0.08%1,7402.99KSep 29, 2024
Wells Fargo & Company0.03%561964Sep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.32%6,59311.34KOct 30, 2024
Fidelity Series Total Market Index Fund0.08%1,5842.72KOct 30, 2024
Vanguard Extended Market Index Fund0.03%6181.06KSep 29, 2024
ATXI insiders
InsiderRelationLatest transactionDateShares held
DAVIDOW ROBERT LBeneficial Owner of more than 10% of a Class of SecuritySaleDec 10, 20230
FORTRESS BIOTECH, INC.Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Apr 15, 20243,547,390
HERSKOWITZ NEILDirectorSaleDec 1, 202497
JIN DAVIDChief Operating OfficerStock Award(Grant)Sep 22, 202465,000
KRANZLER JAY DDirectorSaleNov 4, 2024559
MACLEAN ALEXANDRA M.D.Chief Executive OfficerStock Award(Grant)Sep 22, 2024170,000
Advertisement